Literature DB >> 12650835

Effects of nandrolone on acute morphine responses, tolerance and dependence in mice.

Evelyne Célérier1, Maryam T Yazdi, Anna Castañé, Sandy Ghozland, Fred Nyberg, Rafael Maldonado.   

Abstract

Anabolic-androgenic steroid exposure has been proposed to present a risk factor for the misuse of other drugs of abuse. We now examined whether the exposure to the anabolic-androgenic steroid, nandrolone, would affect the acute morphine responses, tolerance and dependence in rodents. For this purpose, mice received nandrolone using pre-exposure (for 14 days before morphine experiments) or co-administration (1 h before each morphine injection) procedures. Nandrolone treatments increased the acute hypothermic effects of morphine without modifying its acute antinociceptive and locomotor effects. Nandrolone also attenuated the development of tolerance to morphine antinociception in the hot plate test, but did not affect tolerance to its hypothermic effects, nor the sensitisation to morphine locomotor responses. After nandrolone pre-exposure, we observed an attenuation of morphine-induced place preference and an increase in the somatic manifestations of naloxone-precipitated morphine withdrawal. These results indicate that anabolic-androgenic steroid consumption may induce adaptations in neurobiological systems implicated in the development of morphine dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650835     DOI: 10.1016/s0014-2999(03)01462-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

2.  Alterations of the oxidative status in rat hippocampus and prodepressant effect of chronic testosterone enanthate administration.

Authors:  Jovana Joksimović; Dragica Selaković; Vladimir Jakovljević; Vladimir Mihailović; Jelena Katanić; Tatjana Boroja; Gvozden Rosić
Journal:  Mol Cell Biochem       Date:  2017-03-24       Impact factor: 3.396

3.  Subchronic nandrolone administration reduces cocaine-induced dopamine and 5-hydroxytryptamine outflow in the rat nucleus accumbens.

Authors:  Sanna Kurling-Kailanto; Aino Kankaanpää; Timo Seppälä
Journal:  Psychopharmacology (Berl)       Date:  2010-02-26       Impact factor: 4.530

4.  Androgens and opiates: testosterone interaction with morphine self-administration in male rats.

Authors:  Sarah E Cooper; Ruth I Wood
Journal:  Neuroreport       Date:  2014-05-07       Impact factor: 1.837

5.  Testosterone enhances risk tolerance without altering motor impulsivity in male rats.

Authors:  Sarah E Cooper; Sydney P Goings; Jessica Y Kim; Ruth I Wood
Journal:  Psychoneuroendocrinology       Date:  2013-12-01       Impact factor: 4.905

6.  Anabolic-androgenic steroid effects on nociception and morphine antinociception in male rats.

Authors:  K T Tsutsui; R I Wood; R M Craft
Journal:  Pharmacol Biochem Behav       Date:  2011-05-05       Impact factor: 3.533

Review 7.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

Review 8.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

9.  Anabolic-androgenic steroids (AAS) increase sensitivity to uncertainty by inhibition of dopamine D1 and D2 receptors.

Authors:  Kathryn G Wallin-Miller; Frida Kreutz; Grace Li; Ruth I Wood
Journal:  Psychopharmacology (Berl)       Date:  2017-12-14       Impact factor: 4.530

10.  Testosterone and nucleus accumbens dopamine in the male Syrian hamster.

Authors:  Jennifer L Triemstra; Satoru M Sato; Ruth I Wood
Journal:  Psychoneuroendocrinology       Date:  2008-01-30       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.